1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
Svensson, Maria C LU ; Svensson, Maja LU ; Nodin, Björn LU ; Borg, David LU ; Hedner, Charlotta LU ; Hjalmarsson, Claes LU ; Leandersson, Karin LU
and Jirström, Karin
LU
(2022)
In Journal of Innate Immunity
14(6).
p.615-628
- Contribution to journal › Article
- 2021
-
Mark
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy : relationship with histopathological response and survival
Svensson, Maria Christina LU ; Lindén, Albin ; Nygaard, Jakob ; Borg, David LU ; Hedner, Charlotta LU ; Nodin, Björn LU ; Leandersson, Karin LU
and Jirström, Karin
LU
(2021)
In OncoImmunology
10(1).
- Contribution to journal › Article
- 2020
-
Mark
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
Jeremiasen, Martin LU ; Borg, David LU ; Hedner, Charlotta LU ; Svensson, Maria LU ; Nodin, Björn LU ; Leandersson, Karin LU
; Johansson, Jan
LU
and Jirström, Karin
LU
(2020)
In Frontiers in Oncology
10.
- Contribution to journal › Article
- 2019
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
Svensson, Maria C. LU ; Borg, David LU ; Zhang, Cheng ; Hedner, Charlotta LU ; Nodin, Björn LU ; Uhlén, Mathias ; Mardinoglu, Adil ; Leandersson, Karin LU
and Jirström, Karin
LU
(2019)
In Frontiers in Oncology
9(MAR).
- Contribution to journal › Article